340.63MMarket Cap
LossP/E TTM
Atea Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Atea Pharmaceuticals Inc is 6.81, ranking 294 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.06, which is -31.39% below the recent high of -1.41 and -87.01% above the recent low of -3.86.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.